Roland Schmitt Talks Science

When Roland W. Schmitt retired from his job as a senior vice president of General Electric Co. and director of GE’S Research and Development Center on January 31, he had little time to spend in leisure activities. On March 1, the 64-year-old physicist became the 16th president of Rensselaer Polytechnic Institute in Troy, NY He takes over an academic institution that is unique in its links with industry RPI has centers dedicated to interactive computer graphics, manufacturing productivit

Written byPeter Gwynne
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

When Roland W. Schmitt retired from his job as a senior vice president of General Electric Co. and director of GE’S Research and Development Center on January 31, he had little time to spend in leisure activities. On March 1, the 64-year-old physicist became the 16th president of Rensselaer Polytechnic Institute in Troy, NY He takes over an academic institution that is unique in its links with industry RPI has centers dedicated to interactive computer graphics, manufacturing productivity, composite materials and structures, and multiphase phenomena. The institution boasts its own industrial park, populated by a variety of technology-based companies. And the campus possesses “incubator space” designed to nurture small companies during their critical formative stages. Such cooperation has benefited both RPI and industry but now Schmitt faces the question of how strongly the institute should commune with industry in the future.

In a wide-ranging interview with science writer Peter Gwynne, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies